This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wood, G. S. Articles by Sklar, J. Search for Related Content PubMed PubMed Citation Articles by Wood, G. S. Articles by Sklar, J.

American Journal of Pathology, Vol 135, 13-19, Copyright © 1989 by American Society for Investigative Pathology

REGULAR ARTICLES

Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia

GS Wood, BY Ngan, R Tung, TE Hoffman, EA Abel, RT Hoppe, RA Warnke, ML Cleary and J Sklar
Department of Dermatology, Stanford University, California.

Cutaneous lymphoid hyperplasia (CLH) is a disorder characterized by the development of one or more skin lesions containing dense lymphoid infiltrates that exhibit the histopathologic features of a benign, reactive process. Nevertheless, some cases have been associated with the subsequent development of clinically overt lymphomas. This suggests that monoclonal populations may exist in some cases of CLH and that these cases may represent a subset more likely to evolve into lymphoma. To determine if such a subset of CLH can be distinguished, Southern blot analysis of DNA was used to study the immunogenotypic features of lesions from 14 patients with clinical, histopathologic, and immunopathologic findings characteristic of CLH. Five cases exhibited detectable clonal rearrangements of immunoglobulin genes. Furthermore, one of these five cases evolved into overt diffuse large cell lymphoma of B cell lineage during a 2-year follow-up of recurrent disease at the original cutaneous site. The immunoglobulin gene rearrangements of this lymphoma were identical to those of the prior CLH lesion. There was no evidence of detectable t(14;18) chromosomal translocations or clonal rearrangements of the beta gene of the T cell receptor in any case. It was concluded that CLH can be divided into two subsets based on the presence or absence of a clonal B cell population, and that overt lymphoma can arise from the former subset and contain the same B cell clone identified in the pre-existent CLH lesion.

This article has been cited by other articles:

				R. Bergman, Z. Khamaysi, D. Sahar, and Y. Ben-Arieh Cutaneous Lymphoid Hyperplasia Presenting as a Solitary Facial Nodule: Clinical, Histopathological, Immunophenotypical, and Molecular Studies Arch Dermatol, December 1, 2006; 142(12): 1561 - 1566. [Abstract] [Full Text] [PDF]

				A Saxena, E C Alport, O Moshynska, R Kanthan, and M A Boctor Clonal B cell populations in a minority of patients with Hashimoto's thyroiditis J. Clin. Pathol., December 1, 2004; 57(12): 1258 - 1263. [Abstract] [Full Text] [PDF]

				G. S. Wood T-Cell Receptor and Immunoglobulin Gene Rearrangements in Diagnosing Skin Disease Arch Dermatol, November 1, 2001; 137(11): 1503 - 1506. [Full Text] [PDF]

				T. L. Pandolfino, R. S. Siegel, T. M. Kuzel, S. T. Rosen, and J. Guitart Primary Cutaneous B-Cell Lymphoma: Review and Current Concepts J. Clin. Oncol., May 10, 2000; 18(10): 2152 - 2168. [Abstract] [Full Text] [PDF]

				A. Bouloc, M.-H. Delfau-Larue, B. Lenormand, F. Meunier, J. Wechsler, E. Thomine, J. Revuz, J.-P. Farcet, P. Joly, M. Bagot, et al. Polymerase Chain Reaction Analysis of Immunoglobulin Gene Rearrangement in Cutaneous Lymphoid Hyperplasias Arch Dermatol, February 1, 1999; 135(2): 168 - 172. [Abstract] [Full Text] [PDF]

				H. Bachelez The Clinical Use of Molecular Analysis of Clonality in Cutaneous Lymphocytic Infiltrates Arch Dermatol, February 1, 1999; 135(2): 200 - 202. [Full Text] [PDF]